137 related articles for article (PubMed ID: 32352015)
41. Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery.
Lee J; Sohn I; Do IG; Kim KM; Park SH; Park JO; Park YS; Lim HY; Sohn TS; Bae JM; Choi MG; Lim DH; Min BH; Lee JH; Rhee PL; Kim JJ; Choi DI; Tan IB; Das K; Tan P; Jung SH; Kang WK; Kim S
PLoS One; 2014; 9(3):e90133. PubMed ID: 24598828
[TBL] [Abstract][Full Text] [Related]
42. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
43. An immune-related prognostic signature for predicting breast cancer recurrence.
Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
[TBL] [Abstract][Full Text] [Related]
44. A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer.
Song L; Wang XY; He XF
Med Sci Monit; 2019 Aug; 25():6313-6320. PubMed ID: 31422414
[TBL] [Abstract][Full Text] [Related]
45. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer.
Chen S; Liu W; Huang Y
Sci Rep; 2021 Mar; 11(1):7141. PubMed ID: 33785812
[TBL] [Abstract][Full Text] [Related]
46. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
47. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival.
Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ
Front Immunol; 2020; 11():1933. PubMed ID: 33072067
[TBL] [Abstract][Full Text] [Related]
48. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
49. A Robust Circular RNA-Associated Three-Gene Prognostic Signature for Patients with Gastric Cancer.
Li Y; Li R; Wang X; Yuan Y; Zhang Y
Biomed Res Int; 2021; 2021():6633289. PubMed ID: 33969120
[TBL] [Abstract][Full Text] [Related]
50. A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
Li S; Gao J; Xu Q; Zhang X; Huang M; Dai X; Huang K; Liu L
Front Immunol; 2021; 12():693314. PubMed ID: 34177954
[TBL] [Abstract][Full Text] [Related]
51. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
52. A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
Cao B; Luo L; Feng L; Ma S; Chen T; Ren Y; Zha X; Cheng S; Zhang K; Chen C
BMC Cancer; 2017 Dec; 17(1):844. PubMed ID: 29237416
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma.
Shen R; Liu B; Li X; Yu T; Xu K; Ma J
BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781
[TBL] [Abstract][Full Text] [Related]
54. Identification of a novel gene pairs signature in the prognosis of gastric cancer.
Peng PL; Zhou XY; Yi GD; Chen PF; Wang F; Dong WG
Cancer Med; 2018 Feb; 7(2):344-350. PubMed ID: 29282891
[TBL] [Abstract][Full Text] [Related]
55. Development of a novel gene signature in patients without Helicobacter pylori infection gastric cancer.
Lv X; Zhao Y; Zhang L; Zhou S; Zhang B; Zhang Q; Jiang L; Li X; Wu H; Zhao L; Wei M; He M
J Cell Biochem; 2020 Feb; 121(2):1842-1854. PubMed ID: 31633246
[TBL] [Abstract][Full Text] [Related]
56. CT-detected extramural venous invasion-related gene signature for the overall survival prediction in patients with gastric cancer.
Gao B; Feng C; Chai F; Wei S; Hong N; Ye Y; Wang Y; Cheng J
Cancer Med; 2021 Nov; 10(21):7816-7830. PubMed ID: 34510798
[TBL] [Abstract][Full Text] [Related]
57. A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer.
Izumi D; Gao F; Toden S; Sonohara F; Kanda M; Ishimoto T; Kodera Y; Wang X; Baba H; Goel A
EBioMedicine; 2019 Mar; 41():268-275. PubMed ID: 30772302
[TBL] [Abstract][Full Text] [Related]
58. Novel Prognostic Model for Gastric Cancer using 13 Co-Expression Long Non-Coding RNAs (LncRNAs).
Luo X; Su KJ; Qiu C; Liu X; Yang F
Med Sci Monit; 2020 Jun; 26():e923295. PubMed ID: 32480397
[TBL] [Abstract][Full Text] [Related]
59. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract][Full Text] [Related]
60. Tumor Epigenetic Signature and Survival in Resected Gastric Cancer Patients.
Woo Y; Behrendt CE; Yang A; Hahn M; Goel A; Li H; Yuan YC; Fong Y
J Am Coll Surg; 2021 Apr; 232(4):483-491.e1. PubMed ID: 33465468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
